Head-to-head
Found vs Ro
Found and Ro both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Found
Higher scoreRanked #3 · Grade B+
Best for: Parents who want low, identical pricing on either molecule and don't mind a coaching-subscription wrapper around the medication.
Visit FoundRo
Ranked #5 · Grade B
Best for: Parents who specifically want brand-name medication and insurance help, and will trade a fast, price-first decision for a bigger clinical apparatus.
Visit RoThe verdict
Found edges out Ro on the Rx-Readiness Score, 88 to 86 (B+ vs B). Parents who want low, identical pricing on either molecule and don't mind a coaching-subscription wrapper around the medication.
Ro is still a genuine option — a heavyweight platform with brand-name access and insurance navigation — powerful if you want FDA-approved product, but the compounded pricing is opaque and can slow a quick decision. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Found | Ro |
|---|---|---|
| Rx-Readiness Score | 88/100 · B+ | 86/100 · B |
| Overall rank | #3 | #5 |
| Semaglutide | $129/mo | Not disclosed |
| Tirzepatide | $129/mo | Not disclosed |
| Coverage | All 50 states | Multi-state |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Found
Ranked #3 · Grade B+
What we like
- Low, identical flat pricing on both molecules — switching costs you nothing
- Coaching baked in, useful if you want structure without booking a separate service
- Nationwide, with a mostly async onboarding flow
The caveats
- The coaching-subscription model isn't for everyone
- Compounded only — no brand or oral option
- Support cadence can feel program-driven rather than on-demand
Ro
Ranked #5 · Grade B
What we like
- Brand-name (Wegovy/Zepbound) access plus insurance navigation
- Oral options and a well-funded, polished platform
- Deep clinical infrastructure for a more involved path
The caveats
- Compounded pricing isn't posted up front — hard to compare fast
- Insurance and brand routes add steps, not speed
- Premium positioning overall
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Found and Ro against other providers on our shortlist.
Or browse the full comparison hub.